Do MAFLD Patients with Harmful Alcohol Consumption Have a Different Dietary Intake?

Sara Policarpo1,2, Sofia Carvalhana1,3, Ana Craciun3,4

  • 1Laboratório de Nutrição, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal.

Nutrients
|April 12, 2022
PubMed

Insights

This study characterized dietary intake in metabolic-associated fatty liver disease (MAFLD) patients. Alcohol consumption influenced energy, carbohydrate, and fat intake, but not inflammation or fibrosis severity.

Area of Science:

  • Hepatology
  • Nutritional Science
  • Gastroenterology

Background:

  • Metabolic-associated fatty liver disease (MAFLD) is linked to metabolic risk factors.
  • Understanding dietary patterns in MAFLD is crucial for management.
  • Inflammatory characteristics and alcohol intake are key factors in liver disease progression.

Purpose of the Study:

  • To assess the dietary intake of MAFLD patients.
  • To explore the relationship between the Dietary Inflammatory Index (DII®), liver fibrosis, and alcohol consumption in MAFLD.
  • To characterize baseline dietary habits for future interventional trials.

Main Methods:

  • 161 MAFLD patients were included and categorized by alcohol intake (none, moderate, harmful).
  • Dietary intake (kcal/day) and nutrient composition were assessed.
  • Liver fibrosis was evaluated using transient elastography.
  • The Dietary Inflammatory Index (DII®) was used to assess inflammatory potential of diets.

Main Results:

  • Patients with MAFLD and alcohol intake consumed more energy, carbohydrates, and sugar.
  • Harmful alcohol consumption was associated with higher total fat and cholesterol intake.
  • No significant differences in DII® were observed based on fibrosis severity or alcohol consumption levels.

Conclusions:

  • Dietary intake in MAFLD patients varies with alcohol consumption, particularly energy and macronutrient profiles.
  • Current dietary inflammatory index does not correlate with fibrosis severity or alcohol intake in this cohort.
  • Further research is needed to design targeted dietary interventions for MAFLD management.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
443
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
384
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.1K